Spotlight
Video

Significant off-target adverse events from novel treatments directed at molecular targets in CRPC

Loading........
Description: Dr. David Michael Nanus, M.D. of Weill Cornell Medicine discusses significant off-target adverse events from novel treatments directed at molecular targets in CRPC at ASCO GU 2016
Shared By : Genitourinary-Cancer-Meeting
Posted on : 01/12/16
Added : 4 years ago
Category : Prostate Cancer